Weekly Rundown: Small-Cap Stocks with Key Catalysts (September 8-12)

We’ve tracked the latest disclosures and corporate developments to highlight this week’s most impactful small-cap catalysts. Below is our weekly preview for September 8-12.

--

H.C. Wainwright & Co., LLC announced its 27th Annual Global Investment Conference, to be held September 8–10, 2025 at the Lotte New York Palace Hotel in New York City.

Highlights include a keynote by President George W. Bush, moderated by Jenna Bush Hager (September 9, 4:00 p.m. ET), an opening FDA policy panel with former Commissioners Robert Califf and Scott Gottlieb (September 8, 8:00 a.m. ET), and a keynote on Bitcoin and crypto markets by Michael Saylor, Founder and Executive Chairman of MicroStrategy (September 8, 4:00 p.m. ET).

Participating companies include:

LPCN, INM, JAGX, CTSO, AKTX, AGEN, WGRX, IMUX, ARMP, BTAI, GTBP, NXTC, KPRX, SWAG, FUFU, XHLD, ARBE, GRCE, IOBT, AZTR, ZENA, INTZ, CLIR, EEIQ, XPL, FTEK, INUV, TOMZ, PHGE, XTNT, WYY, DYAI, BCDA, URG, MSGM, ASNS, NB, SCWO, DWTX, RIME, SBC, GCL, COCP, GNS, XAIR, SXTP, NRXP, ASRT, PYPD, ENVB, CHRS, BNZI, CASI, MCRP, GRI, MOGO, PHIO, OSTX, ARAI, MNOV, BBLG, VGZ, ERNA, MGNX, CYCU, PSTV, IVP, SSKN, PFSA, MYO, KAPA, LCTX, PDSB, OABI, WHWK, HOWL, IPA, ACHV, GNPX, AMIX, FBIO, CJMB, CAN, SNTI, GALT, ANVS, LSTA, CLDI, INTS, SNGX, OCGN, NMRA, GLUE, CALC, ACET, PLX, AIRE, KTTA, IOVA, VNDA, KZR, CRDF, ATAI, ZNTL, APRE, ATOS, SERA, MRKR, ALEC, PBM, AKBA, EVGN, BEAT, CNTB, ODYS, FBLG, LXRX, EVAX, ENGN, CNTX, VTYX, IVVD, PPBT, SANA, MTVA, ADAG, CMPX, ESPR, ALT, AQST, VYGR, UNCY, KYTX, HYPR, SAVA, EDAP, CLGN, CMMB, PYXS, BMR, SKYE, LGVN, ABSI, VANI, RNTX, HURA, MIST, QSI, LUCY, EDSA, CRIS, AIRJ, AMTX, BLNK, INDO, TCRX, RPID, GNLX, NKTX, ANIX, SLN, ALXO, GOSS, ONCY, CTMX, JSPR, MNKD, NUVB, DRTS, TARA, SVRA, IPSC, IFRX, ANRO, NOTV, PMN, STXS, NSPR, ELUT, CABA, FLUX, SCYX, IMAB, XXII

Lake Street Capital Markets will host its 9th Annual Best Ideas Growth (BIG9) Conference on September 11, 2025, at The Yale Club in New York City.

This invitation-only event brings together dynamic small-cap companies and top institutional investors, offering direct access to senior management through one-on-one and group meeting formats.

Participating companies include:

ACHV, HYPR, RCEL, ONCY, EVAX, BDSX, NOTV, STXS, PSNL, ELUT, FLUX, NNBR, PLBY, PROF, JRSH, CTW, LUNG, KOPN

Morgan Stanley’s 23rd Annual Global Healthcare Conference will take place September 8–10, 2025, at the Sheraton New York Times Square Hotel in New York.

As one of the healthcare industry’s premier gatherings, the event will bring together over 200 companies and a distinguished audience of chief investment officers, portfolio managers, and industry analysts. The agenda features fireside chats with C-level executives, in-depth panels, and one-on-one meetings, designed to foster engagement between top institutional investors and leading healthcare innovators. Discussions will explore emerging opportunities, investment strategies, and partnerships shaping the sector’s future.

Participating companies include:

TCRX, DH, TNYA, ERAS, SLN, AVIR, CTMX, RCKT, SEER, CATX, VIR, CLYM, HCAT, ORGO, PSNL, CABA, SGHT, DCGO, CTKB, PACB, WHWK, NMRA, CRDF, ZNTL, ALEC, RXRX, NAUT, ENGN, PROK, VTYX, SANA, CMPX, PRME, ALT, VYGR, KYTX, RCEL, SKYE, BIOA, ABSI, ABCL, IOBT

Baird’s 2025 Global Healthcare Conference will be held September 9–10, 2025, bringing together institutional and private equity investors with senior management from nearly 100 public and private healthcare companies. Recognized as one of the sector’s preeminent events, the conference offers presentations, idea sharing, and networking opportunities.

Participating companies include:

CHRS, LCTX, EDIT, VOR, ANRO, NOTV, VYGR

Other Companies with Catalysts This Week:

● LUCD / PAVM → Hosting a conference call Sept 8, 8:30 a.m. ET to discuss the Sept 4 CAC Meeting regarding Medicare coverage reconsideration for Lucid’s EsoGuard® Esophageal DNA Test.

● CDZI → Featured in Empowered hosted by Meg Ryan, airing nationwide beginning Sept 8, covering Cadiz’s climate and water infrastructure initiatives.

● GNPX → Presenting at the King Faisal Specialist Hospital & C3 Davos of Healthcare™ New York Summit, Sept 8, Union League Club, NYC.

● EVAX → Multiple conferences: ○ 19th Vaccine Congress, Sept 7–10, Kyoto ○ 6th ESCMID Conference on Vaccines, Sept 10–13, Lisbon ○ Lake Street BIG9 Conference, Sept 12, New York

● ADAG → Oral presentations of ADG126 at the CSCO Meeting, Sept 10–14, Jinan, China.

● BRLT → Presenting at B. Riley Securities 8th Annual Consumer & TMT Conference, Sept 10, Sofitel New York.

● SPWR → Attending RE+ Conference, Sept 8–10, Las Vegas.

● ENTX → Poster presentation at the 47th ESPEN Congress, Sept 13, Prague.

● CLRB → Speaking at the ADC & Novel Conjugates Partnering and Investment Summit, Sept 9, 9:30 a.m. ET.

● NUKK → Closing of $10M private placement expected on or about Sept 9, to fund acquisitions (Tiltan Software, Star 26 Capital, RIMON, Mandragola JV, Blade Ranger license).

● PACK → Presenting full portfolio at IMHX 2025, Sept 9–11, Birmingham, UK.

● IVVD → SPEAR Study Group to present Long COVID study design at RECOVER-TLC Workshop, Sept 9–10, Bethesda, MD.

● ARBE → Showcasing HD Imaging Radar at IAA Mobility 2025, Sept 9–12, Munich.

● AEMD → U.S. Patent 12,409,260 for Long COVID treatment issues on Sept 9.

● KAPA → Presenting Phase 1 ENV105 data at the World Lung Cancer Conference, Sept 6–9, Barcelona.

● CLVT → Presenting at Goldman Sachs Communacopia + Technology Conference, Sept 11.

● OPAD → Fireside chat at Goldman Sachs Communacopia + Tech, Sept 11, 10:10 a.m. PT.

● ACCO → Declared $0.075 quarterly dividend, payable Sept 10 to holders of record Aug 22.

● PYPD → Presenting at Israel Controlled Release Society (ICRS) Conference, Sept 7–9, Dead Sea, Israel.

● DRTS → 1x1 meetings at Oppenheimer Radiopharmaceutical Therapies Summit, Sept 11, NYC.

● NXL → Hosting investor webinar, Sept 9, 4:15 p.m. ET, highlighting DIFS™ neurostimulation tech and Gen-3 HALO™.

● ONDS → Subsidiary American Robotics at CUAS – IDICE 2025, Sept 9–11, San Diego.

● MTEK → Showcasing AI-powered video intelligence at DSEI 2025, Sept 9–12, London.

● IMMP → Presenting TACTI-004 (KEYNOTE-F91) Phase III trial design at World Lung Cancer Conference, Sept 9, Barcelona.

● CURI → Presenting at Singular Research Emerging Growth & Value Alpha Leaders Conference, Sept 10 (virtual at 12:45 ET).

● LWLG → Attending China International Optoelectronic Expo (CIOE), Sept 10–12, Shenzhen; presentation Sept 11.

● XRTX → Investor webinar and Q&A, Sept 10, 4:15 p.m. ET, featuring late-stage gout therapy program XORLO™.

● EDBL → Showcasing sports nutrition and GLP-1 support products at ECRM Vitamin, Weight Management & Sports Nutrition Session, Sept 7–10, Palm Beach Gardens, FL.

● TEAD → Attending Jefferies TechTrek 2025, Sept 10–11, Tel Aviv.

● NXDR → CEO Nirav Tolia fireside chat at Goldman Sachs Communacopia + Tech, Sept 10, 1:25 p.m. PT.

● PMVP → Hosting investor webinar Sept 10, 8:00 a.m. ET with interim Phase 2 PYNNACLE trial data in ovarian cancer.

● TUYA → Declaring $0.054 per share/ADS cash dividend, payable to holders of record as of Sept 11.

● COCP → Oral presentation of CDI-988 at 9th International Calicivirus Conference, Sept 11, Banff, Canada.

● HCWB → Dr. Wong presenting IND-enabling studies at Nova Southeastern University College of Pharmacy Seminar, Sept 12, Fort Lauderdale.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.